Do all prenatal patients require a Group A streptococcus (GAS) swab?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Universal Screening for Group B Streptococcus, Not Group A Streptococcus

No, prenatal patients do not need routine Group A Streptococcus (GAS) swabs—you are likely confusing this with Group B Streptococcus (GBS), which requires universal screening at 36-37 weeks' gestation. 1, 2

Critical Distinction Between GAS and GBS

Group B Streptococcus (GBS) - Universal Screening Required

  • All pregnant women should undergo universal screening for GBS colonization between 36 0/7 and 37 6/7 weeks' gestation with both vaginal and rectal specimens. 1, 2
  • The CDC and ACOG recommend this screening to prevent early-onset neonatal disease, which occurs in 1-2% of exposed newborns without prophylaxis. 2
  • Women with positive GBS cultures receive intrapartum antibiotic prophylaxis (penicillin G 5 million units IV initially, then 2.5 million units IV every 4 hours until delivery). 1
  • Women with GBS bacteriuria at any concentration during pregnancy receive intrapartum prophylaxis without need for additional screening. 1

Group A Streptococcus (GAS) - No Routine Screening

  • There is no recommendation for routine prenatal GAS screening in asymptomatic pregnant women. 3
  • GAS screening is only indicated during outbreak investigations or when healthcare-associated infection is suspected. 3
  • Pregnancy-related GAS infections are rare (0.8 cases per 1000 live births) and typically occur postpartum, not prenatally. 4

When GAS Testing Is Appropriate in Pregnancy

Symptomatic Infection

  • Pregnant women with signs of GAS infection (fever, pharyngitis, skin lesions, genital tract infection) should be tested and treated at the time of diagnosis. 3
  • Documentation of GAS infection should be clearly noted in maternity records. 3

Outbreak Investigation

  • GAS isolates from peripartum patients should be saved for six months to facilitate outbreak investigation if needed. 3
  • Screening of healthcare workers and environmental sources occurs only during outbreak investigations, not routinely. 3

Common Pitfalls to Avoid

  • Do not confuse GAS with GBS—the screening protocols are completely different, and only GBS requires universal prenatal screening. 1, 2
  • Do not order routine GAS swabs on asymptomatic pregnant women—this is not evidence-based and wastes resources. 3
  • Do not delay treatment if a pregnant woman has documented GAS infection earlier in pregnancy—treat at the time and document clearly. 3
  • Maternal deaths from GAS genital tract sepsis increased from 1 per year (2000-2002) to 4 per year (2006-2008) in the UK, emphasizing the importance of recognizing symptomatic infection. 3

Risk Factors for Postpartum GAS Infection

  • Vaginal delivery (cesarean delivery is protective with perioperative antibiotics). 4
  • Multiparity (primiparous women have lower risk, likely due to less exposure to children who carry GAS). 4
  • Recent respiratory tract infection or family members with sore throats. 3
  • The infection typically manifests postpartum with fever and abdominal tenderness, not during routine prenatal care. 4

References

Guideline

Prevention and Treatment of Group B Streptococcus in Pregnancy and Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Risk factors, clinical course and outcomes of pregnancy-related group A streptococcal infections: retrospective 13-year cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.